Economic pressures and an increasing scarcity of expertise give rise to the Virtual Scientific Workplace

The Burrill Report

The Burrill Report - Sponsored Podcast - The Virtual Scientific Workplace (.MP3,9.43 Mb)

Economic pressures and an increasing scarcity of expertise is leading companies to embrace new virtual networks models to draw on skilled scientific workers from around the globe to collaborate and share knowledge. In this final part of a three-part series of podcasts by The Burrill Report, produced in conjunction with Kelly Services, Harvey Yau, prodcuct manager for Kelly Services Americas Scientific Product Group, discusses the emergence of virtual networks in the life sciences, the benefits they provide, and what companies will need to do to be successful with these new workplace models.

DIA wants you to continue to benefit from opportunities to learn and grow professionally, year-round.

DIA’s Annual Meeting Comes Once a Year. Were You There? If you missed this year’s DIA Annual Meeting, you can now purchase content that was delivered at this year’s program! DIA wants you to continue to benefit from opportunities to learn and grow professionally, year-round.      • View available presentations for 280 + educational offerings        captured in digital audio with synchronized slides      • Download available offerings in MP3 format to your mobile        device for portable listening      • Check out the DIA 2012 Annual Meeting final program and see        all the special topics that were covered The DIA 2012 48th Annual Meeting includes a comprehensive coverage of today's hottest topics, such as PDUFA V, biosimilars, tailored therapies, personalized medicine, social media, region-specific content, and much more! Entire Meeting Package: $799.99 Individual Session Price: $59.99 Track Price: $199 - $299 Read issues of the DIA 2012 48th Annual Meeting "Show Daily" Weekend issue Monday's issue Tuesday's issue Wednesday's issue DIA 2013 49th Annual Meeting Call for Abstracts Now Open! DIA 2013 49th Annual Meeting “Advancing Therapeutic Innovation and Regulatory Science” June 23-27, 2013 Boston, MA Submission Deadline: COB, September 12 Abstract Guidelines Submit Abstract Online See What You Missed at DIA 2012 48th Annual Meeting in Philadelphia… Hear FDA's Margaret Hamburg discuss how three of the most influential regulatory agencies--FDA, EMA, and Health Canada--can collaborate to harmonize technical requirements under the ICH; establish confidentiality arrangements; collaborate on inspection pilots; exchange working level scientific and regulatory policies, procedures, and reports; and implement technical level "clusters" of agency reviewers. Read a complete session follow-up. Questions? For questions related to the content of the Annual Meeting program, email the Annual Meeting Team. Technical Difficulties? If you experience technical difficulties while purchasing, please contact multiviewmediasupport@multiview.com or call 289-695-5400. Note: Continuing education credits are NOT available for archived content accessed through the Live Learning Center. Content available for 18 months and will expire on December 28, 2013.

#DIA2012 - Highlights for Wednesday, June 27

#DIA2012 - Tuesday, June 26 Highlights

 

Collaborate to Innovate - #DIA2012 June 24-28 Philadelphia

4 Days. 22 Tracks. 270+ Educational Offerings. 500+ Exhibitors. 7,500+ Attendees. The DIA 2012 48th Annual Meeting offers the most comprehensive and robust learning and networking opportunities to help you find solutions to the challenges you face in the discovery, development, and life cycle management of biopharmaceuticals, biotechnology, medical devices, and related products. Top biopharmaceutical thought leaders will be at the DIA 2012 Annual Meeting to pass on their expertise directly to you. Life Science Entrepreneur Pavilion Network with Entrepreneurs in this year’s new Life Science Entrepreneur Pavilion and discuss how they are changing the future development of new medicines. Pfizer is pleased to support the Life Science Entrepreneur Pavilion at this year’s DIA 2012 Annual Meeting. Funding Funding Innovation and Creating Opportunities in the Device, Diagnostic, and Drug Interface Partnering Models-Public Private Partnerships Pre-competitive Public Private Partnerships: The Changing Model of Pharmaceutical R&D How Industry Can Partner with FDA in Defining a Risk-based Monitoring Program Multistakeholder Development Partnerships: Harnessing Differing Perspectives, Objectives, and Strengths for Success Vaccines Vaccines: FDA and Japan Perspectives Integrated Partnership: A Vaccine Case Study Biotech First-in-human Challenges of Biologics and Biosimilars Product Candidate to Proof-of-concept: An Integrated Approach to Accelerate Programs Regulatory Affairs for Biologics Biomarker Focused Strategies for Personalized Medicine Understanding Comparative Effectiveness Research (CER) in the Biopharmaceutical Industry Other Special Topics Analysis and Impact of PDUFA V: How the Changes Will Affect the Work of Regulatory Affairs Professionals Pediatric Development in the US: Implementation of 2007 PREA and BPCA Against a Backdrop of the EU Pediatric Legislation CBER Town Hall CDER Town Hall: Part 1 of 2 CDER Town Hall: Part 2 of 2 Regulatory Roundtable on Biosimilars Update on Biosimilar Developments in the US Emerging Development and Policy Trends in the Economics of the Biopharmaceutical Industry Risks to and Securing of Global Drug Supply Chains Partnering for Impact in Global Health Executive Program: Pioneering Partnerships Much more! Register Online | Program Overview Group Discounts Available! Register 10 individuals from your company and receive the 11th FREE! Contact your group discount representative for details!

My DIA |

800 Enterprise Road, Suite 200
Horsham, Pennsylvania 19044-3595
T. +1.215.442.6100
F. +1.215.442.6199email: annualmeetingprogram@diahome.org